Trenchant Completes Initial Investment in GNQ Insilico Inc.
Trenchant Completes Initial Investment in GNQ Insilico Inc.
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Trenchant Capital Corp. (CSE: TCC) (the "Company") is pleased to announce that pursuant to an option agreement between the Company and GNQ Insilico Inc. ("GNQ") dated November 30, 2023, as amended from time to time ( the "Option Agreement"), it has acquired 20% of the total issued and outstanding common shares in the capital of GNQ (the "Initial Investment").
不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2024 年 5 月 1 日)— Trenchant Capital Corp.(CSE:TCC)(”公司“)很高興地宣佈,根據公司與GNQ Insilico Inc.之間的期權協議(”GNQ“) 日期爲 2023 年 11 月 30 日,經不時修訂(”期權協議“),它已收購了GNQ資本中已發行和流通普通股總額的20%(”初始投資“)。
Concurrently with closing the Initial Investment, the Company entered into an amendment agreement to the Option Agreement pursuant to which the parties agreed to complete the Initial Investment with the payment by the Company to GNQ of $650,000, the issuance of 7,500,000 common shares in the capital of the Company (each, a "Share"), and the issuance of 2,600,000 units (each, a "Unit") at a deemed issue price of $0.25 per Unit, on or prior to April 29, 2024. Each Unit is comprised of one Share and one warrant (each, a "Warrant") to purchase one Share (each, a "Warrant Share") at an exercise price of $0.50 per Warrant Share until April 29, 2026. The Shares issued to GNQ, and any Warrant Shares issued upon the due exercise of the Warrants, are subject to a voluntary lock-up whereby 50% of the Shares and any Warrant Shares are restricted from transfer until April 29, 2025, and the remaining 50% are restricted from transfer until April 29, 2026.
在完成初始投資的同時,公司簽訂了期權協議的修訂協議,根據該協議,雙方同意完成初始投資,公司向GNQ支付65萬美元,發行公司資本中的7,500,000股普通股(每股均爲”分享“),以及發行 2,600,000 個單位(每個,一個”單元“)在2024年4月29日當天或之前,按每單位0.25美元的認定發行價格計算。每個單位由一股股票和一份認股權證組成(每股均爲”搜查令“) 購買一股(每股,一股”認股權證“)在2026年4月29日之前,每股認股權證的行使價爲0.50美元。向GNQ發行的股份以及在到期行使認股權證時發行的任何認股權證股份均受自願封鎖限制,其中50%的股份和任何認股權證股份在2025年4月29日之前不得轉讓,其餘50%的股份在2026年4月29日之前只能轉讓。
Pursuant to the Option Agreement, the Company may acquire an aggregate of 40% of the total issued and outstanding GNQ Shares by investing an additional $5,000,000 in GNQ at any time prior to November 30, 2026 (the "Option Period"). Subject to the acquisition of 40% of the total issued and outstanding GNQ Shares, the Company may exercise the Option to acquire 50% of the total issued and outstanding GNQ Shares by investing an additional $10,000,000 in GNQ at any time prior to the expiry of the Option Period.
根據期權協議,公司可以在2026年11月30日之前的任何時候通過向GNQ額外投資500萬美元來收購已發行和流通的GNQ股票總額的40%(”期權期“)。在收購已發行和流通的GNQ股票總額的40%的前提下,公司可以在期權期到期前的任何時候通過向GNQ額外投資1,000,000美元來行使期權,收購已發行和流通的GNQ股票總額的50%。
Upon closing of the Initial Investment, GNQ acquired, as consideration from the Company, 7,500,000 Shares and 2,600,000 Units together with additional cash consideration. In aggregate, GNQ now beneficially owns a total of 10,100,000 Shares and 2,600,000 Warrants, with such Warrants exercisable for an additional 2,600,000 Shares, representing 17.0% of the total issued and outstanding Shares on an undiluted basis (or 19.9% on a partially diluted basis assuming the Warrants are exercised up to the maximum percentage permitted by the terms of the Warrants). Prior to the Initial Investment, GNQ did not own any securities of the Company. The aggregate value of the 7,500,000 Shares issued is $150,000 and the aggregate value of the Units is $650,000, resulting in a total aggregate value of $800,000, plus $1,850,000 in additional cash consideration paid in the previous tranches of the Initial Investment. The Shares and Units were acquired for investment purposes and in the future, additional securities of the Company may be acquired or disposed of by GNQ as circumstances or market conditions may warrant.
初始投資完成後,GNQ以對價從公司手中收購了7,500,000股股票和2,600,000個單位以及額外的現金對價。總體而言,GNQ現在共擁有10,100,000股股票和2,600,000股認股權證,此類認股權證可額外行使2,600,000股,佔未稀釋的已發行和流通股份總數的17.0%(假設認股權證的行使不超過認股權證條款允許的最大百分比,則按部分攤薄後的19.9%)。在進行初始投資之前,GNQ不擁有公司的任何證券。已發行的7,500,000股股票的總價值爲15萬美元,單位的總價值爲65萬美元,總價值爲80萬美元,外加在前一批初始投資中支付的185萬美元額外現金對價。收購這些股份和單位是出於投資目的,將來,GNQ可能會在情況或市場條件允許的情況下收購或處置公司的其他證券。
GNQ
GNQ
GNQ () was formed in August 2023 by My Next Health Inc. ("MNH"), a Delaware incorporated healthcare company with a vision to improve the global healthcare sector by deploying a genomics-based AI and quantum platform for clinical trials and point of care solutions. MNH's platform uses proprietary insights on how systems of genes interact with each other as well as with epigenetic factors to drive key metabolic pathways. These insights are based on more than 15,000 case studies conducted over a decade and are now being scaled and commercialized through a platform that will leverage key exponential technologies to revolutionize personalized healthcare. MNH has exclusive and perpetual global rights to the use of certain technology that relates to functional genomics as well as the supporting clinical data, programs, methods, and interpretation know-how and analytics for use in a number of commercial applications. On November 6th, 2023, GNQ signed a Memorandum of Understanding with a Fortune 100 company towards the development of the in silico clinical trials platform and on March 6, 2024, GNQ announced that it has commenced the development of the platform with the Fortune 100 company. The full corporate update can be accessed here: .
GNQ () 由 My Next Health Inc. 於 2023 年 8 月成立 (”MNH“),一家在特拉華州註冊成立的醫療保健公司,其願景是通過部署基於基因組學的人工智能和量子平台進行臨床試驗和護理點解決方案,改善全球醫療保健行業。MNH的平台使用有關基因系統如何相互作用以及與表觀遺傳因子相互作用的專有見解來推動關鍵代謝途徑。這些見解基於十年來進行的15,000多個案例研究,目前正在通過一個平台進行擴展和商業化,該平台將利用關鍵指數技術徹底改變個性化醫療保健。MNH擁有使用與功能基因組學相關的某些技術以及用於多種商業應用的支持性臨床數據、項目、方法、解釋知識和分析的獨家和永久的全球權利。在 11 月 6 日第四2023年,GNQ與一家財富100強公司簽署了諒解備忘錄,以開發模擬臨床試驗平台。2024年3月6日,GNQ宣佈已開始與財富100強公司開發該平台。完整的公司更新可在此處訪問:.
Further to its News Release of April 18, 2024, the Company has closed a first tranche of the non-brokered private placement financing (the "Offering") pursuant to which it has issued an aggregate of 450 convertible debenture units (each, a "Debenture Unit") at a price of $1,000 per Debenture Unit for gross proceeds of $450,000. Each Debenture Unit is comprised of: (i) $1,000 principal amount unsecured convertible debenture (each, a "Debenture"); and (ii) 1,000 common share purchase warrants (each, a "Debenture Warrant"). Each Debenture Warrant will entitle the holder thereof to acquire one Share (each, a "Debenture Warrant Share") at a price of $0.26 per Debenture Warrant Share for a period of two years following closing. The principal amount of the Debenture will have a maturity date one year following the issuance of the Debentures and will accrue interest at a rate of 10% per annum.
繼2024年4月18日發佈新聞稿之後,該公司已經完成了第一批非經紀私募融資(”提供“) 據此,它共發行了450個可轉換債券單位(每單位a”債券單位”) 每個債券單位的價格爲1,000美元,總收益爲45萬美元。每個債券單位包括:(i)本金1,000美元的無抵押可轉換債券(每個單位均爲”債券“);以及 (ii) 1,000份普通股購買權證(每份爲一份”債券認股權證“)。每份債券認股權證將賦予其持有人收購一股股份的權利(每股,一股”債券認股權證“)每股債券認股權證的價格爲0.26美元,期限爲收盤後的兩年。債券的本金將在債券發行後一年的到期日,並將按每年10%的利率累計利息。
At the sole option of the subscriber, the principal amount and accrued interest thereon may be converted into Shares of the Company at a conversion price (the "Conversion Price") determined by the closing market price (the "Market Price") of the Shares on the Canadian Securities Exchange (the "CSE") on the trading day prior to the date the Company receives a Notice of Conversion from the subscriber, provided that the Conversion Price will not be less than $0.26 per Share, and subject to the policies of the CSE. On the maturity date, at the sole option of the Company, the principal amount and any accrued interest thereon may be converted into Shares at the Conversion Price, subject to the policies of the CSE. Proceeds of the Offering were used for the Company's initial investment in GNQ. The securities issued in connection with the Offering, and the Shares that may be issuable on exercise of the Debenture Warrants and conversion of the Debentures and interest, are subject to a statutory hold period expiring four months and one day after closing of the Offering.
訂戶可以選擇將本金及其應計利息按轉換價格轉換爲公司股份(”轉換價格“)由收盤市價決定(”市場價格“)加拿大證券交易所的股票(”案例“)在公司收到訂閱者轉換通知之日的前一個交易日,前提是轉換價格不低於每股0.26美元,並受CSE政策的約束。在到期日,本金及其任何應計利息可以按轉換價格轉換爲股票,由公司自行選擇,但須遵守CSE的政策。本次發行的收益用於公司對GNQ的初始投資。與本次發行相關的證券以及在行使債券認股權證和轉換債券和利息時可能發行的股票的法定持有期將在發行結束後四個月零一天到期。
The Offering is considered a related party transaction under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions, as a director of the Company participated in the Offering. The Company did not file a material change report more than 21 days before the closing date of the Offering as the details of the Offering and the participation therein by each related party of the Company were not settled until shortly prior to the closing of the Offering and the Company wished to close the Offering on an expediated basis for business reasons.
根據第61-101號多邊文書,本次發行被視爲關聯方交易 在特殊交易中保護少數證券持有人,作爲公司董事參與了本次發行。該公司在發行截止日期前21天沒有提交重大變更報告,因爲本次發行的細節以及公司每個關聯方的參與情況直到本次發行結束前不久才確定,公司出於業務原因希望儘快結束本次發行。
A finder's fee of 1,750,000 Units was paid in connection with the Option Agreement to an arm's length third-party.
根據期權協議,向獨立第三方支付了1750,000個單位的發現費。
ON BEHALF OF THE BOARD
代表董事會
TRENCHANT CAPITAL CORP.
TRENCHANT CAPITAL CORP
Per: "Eric Boehnke"
每個: “Eric Boehnke”
Eric Boehnke, CEO
首席執行官埃裏克·博恩克
For further information, please contact:
欲了解更多信息,請聯繫:
Trenchant Capital Corp.
Eric Boehnke, CEO
Phone: (604) 307-4274
Trenchant 資本公司
首席執行官埃裏克·博恩克
電話:(604) 307-4274
TRENCHANT CAPITAL CORP.
TRENCHANT CAPITAL CORP
Certain statements in this press release are forward-looking statements, which reflect the expectations of management regarding the Company's exercise of the Option and related transactions. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, statements regarding MNH's and GNQ's business and potential in the industries in which they operate, the Company completing the transactions as described herein or at all, including the exercise of the remaining Option, the obligations to be satisfied under the Option Agreement, the Offering and its terms, including the intended use of proceeds of the Offering and additional tranches of the Offering may not close on the terms announced or at all. Such statements are subject to risks and uncertainties that may cause actual results, performance, or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include that the business of MNH and GNQ may not be feasible or continue as planned, that exercising the Option may not be an optimal business strategy due to market conditions during the Option Period, as well as other risks that are customary to transactions of this nature. Further, inflationary pressures, rising interest rates, the global financial climate and the ongoing conflicts in Ukraine and the Middle East and surrounding regions are some additional factors that are affecting current economic conditions and increasing economic uncertainty, which may impact the operating performance, financial position, and future prospects of the Company, MNH, GNQ, and the transaction as a whole. Collectively, the potential impacts of this economic environment pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
本新聞稿中的某些陳述是前瞻性陳述,反映了管理層對公司行使期權和相關交易的預期。前瞻性陳述由不純粹是歷史的陳述組成,包括有關未來信念、計劃、預期或意圖的任何陳述,包括但不限於有關MNH和GNQ在其經營行業中的業務和潛力、公司按本文所述完成交易或包括行使剩餘期權、期權協議、本次發行及其條款應履行的義務,包括收益的預期用途的陳述的本次發行和本次發行的額外部分可能不會按照宣佈的條款結束,也可能根本無法結束。此類陳述存在風險和不確定性,可能導致實際業績、業績或發展與聲明中包含的結果存在重大差異,包括與公司無法控制的因素相關的風險。風險包括MNH和GNQ的業務可能不可行或無法按計劃繼續,由於期權期內的市場狀況,行使期權可能不是最佳的業務策略,以及此類性質交易中習慣存在的其他風險。此外,通貨膨脹壓力、利率上升、全球金融環境以及烏克蘭和中東及周邊地區持續的衝突是影響當前經濟狀況和增加經濟不確定性的其他因素,可能會影響公司、MNH、GNQ和整個交易的經營業績、財務狀況和未來前景。總的來說,這種經濟環境的潛在影響構成了目前難以描述和無法估量的風險。無法保證前瞻性陳述所預期的任何事件都會發生,也無法保證如果發生的話,公司將從中獲得什麼好處。除非法律要求,否則公司不打算或義務更新或修改任何前瞻性陳述,無論是由於新信息、未來事件還是其他原因。
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
加拿大證券交易所和市場監管機構(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
譯文內容由第三人軟體翻譯。